Neutrophil-to-Lymphocyte and Platelet-to-lymphocyte Ratios as a Predictor Factors for Chronic Kidney Disease Progression

Launched by ASSIUT UNIVERSITY · Oct 31, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to find out if certain blood test measurements, called Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR), can help predict how quickly kidney function declines in patients with chronic kidney disease (CKD). The study will include 200 patients who are between 18 and 65 years old and have been diagnosed with CKD. Unfortunately, people outside this age range, pregnant women, and those with certain other health issues like diabetes or active infections won't be able to participate.

If you or a loved one qualifies for this study, you can expect to have your blood tested to measure the NLR and PLR levels. The trial has not started recruiting participants yet, but it aims to understand more about CKD and how it progresses, which could help improve future treatments and care for patients. It's an opportunity to contribute to important research that may benefit others dealing with similar health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 200 Patients diagnosed with CKD and their age range between 18-65 years old who will be admitted at AUH.
• Exclusion Criteria:
• • 1. Pediatric patients aged below\< 18 or elderly patients aged above 65.
• • 2. Pregnant females.
• • 3. Patients with Diabetes Mellitus.
• • 4. Acute kidney injury (AKI).
• • 5. Patients with current infections.
• • 6. Patients who have any type of malignancy.
• • 7. Patients who have any type of multi-organ failure.
• • 8. CKD patients on dialysis